CADIME

Centro Andaluz de Documentación e Información de Medicamentos

CADIME

Centro Andaluz de Documentaci&ocute;n e Información de Medicamentos

Noticia

 

Más artículos de interés

21 de diciembre de 2018

Noviembre, diciembre/2018

A continuación, presentamos un listado de artículos que no se publicaron entre las noticias y destacados que enviamos cada semana pero que pueden ser de interés para el tratamiento de un paciente determinado, para cuando revisamos una patología o tratamiento, para mantenerse actualizados o por cualquier otra razón.

La intención es poner a disposición de los profesionales sanitarios una selección de artículos que no se han noticiado pero que pueden ser igualmente interesantes.

Los profesionales del Sistema Sanitario Público de Andalucía pueden acceder a los artículos originales disponibles a través de la Biblioteca Virtual de Andalucía.

 

  • Buprenorphine-naloxone (Suboxone) for pharmaceutical opioid use disorder. ACFP

 

  • The next stage of buprenorphine care for opioid use disorder. Ann Intern Med

 

 

  • Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis. BMJ

 

  • A trial of a triple-drug treatment for lymphatic filariasis. NEJM

 

  • Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease. Circulation

 

  • Vitamin D supplements and prevention of cancer and cardiovascular disease. NEJM

 

  • Dapagliflozin and cardiovascular outcomes in type 2 diabetes. NEJM

 

  • Angiotensin–neprilysin inhibition in acute decompensated heart failure. NEJM

 

  • Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. NEJM

 

 

  • Adverse drug reactions. BMJ

 

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. The Lancet

 

  • Evaluation and management of youth-onset type 2 diabetes: a position statement by the american diabetes association. Diabetes Care

 

  • Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ

 

  • Ischaemic heart disease and pregnancy. BMJ Heart

 

  • Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. EMA

 

 

  • Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable. European heart Journal

 

  • Denosumab (Prolia°) and osteoporosis: an increasingly unfavourable harm-benefit balance. Prescrire in English

 

 

  • 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease. A report of the american college of cardiology task force on expert consensus decision pathways. JACC

 

 

 

  • Assessment of pregabalin postapproval trials and the suggestion of efficacy for new indications. A systematic review. JAMA Internal Medicine

 

  • The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis. BMJ Open

 

 

  • Neuropathic pain – definition and drug therapy. Aust Prescr

 

  • A summary of prescribing recommendations from NICE guidance. NICE Bites

 

  • Assessing the association between glp-1 receptor agonist use and diabetic retinopathy through the fda adverse event reporting system, Diabetes Care

 

  • Bacterial vaginosis and desquamative inflammatory vaginitis. NEJM

 

  • Finding the balance between benefits and harms when using statins for primary prevention of cardiovascular disease: a modeling study. Ann Intern Med

 

  • Drug-associated infective endocarditis trends: what's all the buzz about? Ann Intern Med

 

 

 

  • Post-traumatic stress disorder. NICE

 

  • NICE recomienda tofacitinib para la colitis ulcerosa de moderada a grave. Prescriber

 

 

 

  • Identification of patients at-risk of QT interval prolongation during medication reviews: a missed opportunity? J Clin Med

 

 

 

 

 

  • Objetivo óptimo de presión arterial sistólica en la hipertensión resistente y no resistente. Salud juntos

 

  • Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a french equivalence study. Ann Intern Med

 

 

  • Topical capsaicin for neuropathic and osteoarthritis pain: maybe not so hot? ACFP

 

 

  • Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. NEJM

 

 

 

  • Review: In chronic noncancer pain, cannabinoids reduce pain (NNT 24) but increase adverse events (NNH 6). Ann Intern Med

 

  • Increasing evidence for the limited role of opioids to treat chronic noncancer pain. JAMA

 

  • Association of metformin use with vitamin B12 deficiency in the institutionalized elderly. Arch Gerontol Geriatr

 

  • Diagnosis and Management of Nonalcoholic Fatty Liver Disease. JAMA

 

  • Hand, Foot, and Mouth Disease. JAMA

 

 

Permalink:
http://www.cadime.es/?iid=articulos-noviembre-diciembre-2018&itid=3&lan=es
Descargar PDF
Valorar noticia Valorar noticia
Fecha de última actualización: 21/12/2018